[1] Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. [2] Ferlay J, Colombet M, Soerjomataram I, et al.Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer, 2019, 144(8): 1941-1953. [3] Zieren HU, Müller JM, Jacobi CA, et al.Adjuvant Postoperative Radiation Therapy after Curative Resection of Squamous Cell Carcinoma of the Thoracic Esophagus: A Prospective Randomized Study[J]. World J Surg, 1995, 19(3): 444-449. [4] Zhang W, Liu X, Xiao Z, et al.Postoperative intensity-modulated radiotherapy improved survival in lymph node-positive or stage III thoracic esophageal squamous cell carcinoma[J]. Oncol Res Treat, 2015, 38(3): 97-102. [5] Chen SB, Weng HR, Wang G, et al.The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma[J]. J Cancer Res Clin Oncol, 2016, 142(1): 277-286. [6] Yang J, Zhang W, Xiao Z, et al.The Impact of Postoperative Conformal Radiotherapy after Radical Surgery on Survival and Recurrence in Pathologic T3N0M0 Esophageal Carcinoma: A Propensity Score-Matched Analysis[J]. J Thorac Oncol, 2017, 12(7): 1143-1151. [7] Deng W, Yang J, et al.Postoperative Radiotherapy in Pathological T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study[J].Oncologist, 2020, 25(4): e701-e708. [8] Liu Q, Cai XY, Fu XL, et al.Tolerance and does-volume relationship of intrathoracic stomach irradiation after esophagectomy for patients with thoracic esophageal squamous cell carcinoma[J]. Oncotarget, 2015, 6(31): 32220-32227. [9] Qiao XY, Wang W, Zhou ZG, et al.Comparison of efficacy of regional and extensive clinical target volumes in postoperative radiotherapy for esophageal squamous cell carcinoma[J]. Int J Radiat Oncol Biol Phys, 2008, 70(2): 396-402. [10] Zhu Y, Li M, Kong L, et al.Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation[J]. Onco Targets Ther, 2016, 7(11): 4187-4196. [11] Liu Q, Cai XW, Wu B, et a1. Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma:implications for the clinical target volume design of postoperative radiotherapy[J]. Plos One, 2014, 9(5): e97225. [12] Li CL, Zhang FL, Wang YD, et al.Characteristics of recurrence after radical esophagectomy with two-field lymph node dissection for thoracic esophageal cancer[J]. Oncol Lett, 2013, 5(1): 355-359. [13] Zhu Y, Li M, Kong L, et al.Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation[J]. Onco Targets Ther, 2016, 9: 4187-4196. [14] Liu J, Cai XW, Liu Q, et al.Characteristics of the local recurrence pattern after curative resection and values in target region delineation in postoperative radiotherapy for lower thoracic esophageal squamous cell cancer[J]. Thorac Cancer, 2017, 8(6): 630-633. [15] Ahmed MM, Guha C, Hodge JW, et al.Immunobiology of radiotherapy: new paradigms[J]. Radiat Res, 2014, 182(2): 123-125. |